Dr. Francine Evalina Garrett-bakelman MD/PHD
Hematologist-Oncologist | Hematology & Oncology
525 East 68th Street,Nyph, Wcmc Payson Pavillion, 3r New York NY, 10065About
Francine Evalina Garrett-Bakelman, MD, PhD, is an Instructor in Medicine in the Hematology and Medical Oncology Division of the Medicine Department. She is also appointed as an Assistant Attending Physician ...
Education and Training
Albert Einstein Medicine
Board Certification
Internal MedicineAmerican Board of Internal MedicineABIM
Internal MedicineAmerican Board of Internal MedicineABIM- Hematology- 2012
Provider Details
Expert Publications
Data provided by the National Library of Medicine- Differentiation therapy for IDH1/2 mutant malignancies.
- Dnmt3a regulates myeloproliferation and liver-specific expansion of hematopoietic stem and progenitor cells.
- Mutant IDH: a targetable driver of leukemic phenotypes linking metabolism, epigenetics and transcriptional regulation.
- is a key regulator of myeloid/erythroid differentiation and DNA methylation in hematopoietic stem/progenitor cells.
Professional Memberships
- Member STUDENT NATIONAL MEDICAL ASSOCIATION
- Member NATIONAL MEDICAL ASSOCIATION
- Member AMERICAN SOCIETY OF HEMATOLOGY
- Member American Society of Clinical Oncology
Fellowships
- NewYork-Presbyterian Hospital/ Weill Cornell Medical Center
Dr. Francine Evalina Garrett-bakelman MD/PHD's Practice location
Dr. Francine Evalina Garrett-bakelman MD/PHD's reviews
Write ReviewRecommended Articles
- Promising Results for Hodgkin Patients Using This Therapy
Researcher Dr. Bradford S. Hoppe and his colleagues at the University of Florida College of Medicine have recently found that the addition of proton therapy to first-line chemotherapy regimens may improve outcomes for patients with Hodgkin lymphoma.Lymphoma is classically treated with both...
- The Lymphoma Research Foundation's Light it Red for Lymphoma Night
Lymphoma, a cancer of the lymphatic system, currently affects over 700,000 Americans who are living with or in remission from the disease. Statistics show that every seven minutes, someone in the United States is diagnosed with the condition, which amounts to approximately 80,000 people per year.The...
- Astonishing Clinical Trial Results Show Promise for Non-Hodgkin Lymphoma Research
There’s good news for those who’ve been diagnosed with the aggressive non-Hodgkin lymphoma (NHL) type referred to as diffuse large-B cell (DLBCL). According to the American Cancer Society (ACS), this type of HNL is the most common type of lymphoma.The descriptive letters clarify the type of...
- Woman Who Battled Lymphoma Three Times Starts Support Group
Battling cancer is just that - a battle. To make it through once is an incredible feat, but one Virginia Beach woman survived the terrible condition three times. Now, she is starting a support group so other women can have the incredible outcome she had as well.Lynne's storyUnfortunately, most...
- How is Multiple Myeloma Diagnosed?
Various tests are conducted for the diagnosis of multiple myeloma since one result of a laboratory test cannot diagnose it alone. A number of factors like the history, complete body check-up, diagnostic test reports and symptoms of the patient are taken into consideration to get a proper diagnosis...
- What are the Stages of Multiple Myeloma?
This is the uncommon type of cancer that forms in plasma cells. A type of white blood cells found in the body, plasma cells, identify and battle germs and infections that attack the body.In multiple myeloma patients, the healthy plasma cells are overtaken by cancer cells. This reduces the number of...
Nearby Providers
- David Jin6 Clinton Court Staten Island New York 10301
- Dr. Inna Sominsky M.D.1660 E 14th St Brooklyn NY 11229
- Amandeep Kaur MD355 Bard Ave Staten Island NY 10310
- Pilar Nava-Parada20 W 72nd St New York NY 10023
- Dr. LiHong Wei M.D.17660 Union Tpke Fresh Meadows NY 11366
- Loreta Garretson-Vaivilavicius Other96 Parkway Rochelle Park NJ 07662